FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1570364834> ?p ?o ?g. }

• W1570364834 endingPage "320" @default.
• W1570364834 startingPage "311" @default.
• W1570364834 abstract "Background Deregulation of the proteasome pathway has been shown to be involved in the pathogenesis of several inflammatory disorders. To date limited information exists on proteasome and immunoproteasome expression and activity in psoriasis skin. Objectives To investigate the potential role of proteasomes in the pathogenesis of psoriasis. Methods Thirty‐six patients with psoriasis and 40 healthy subjects were included. The protein and mRNA expression levels and proteolytic activity of proteasome and immunoproteasome subunits were determined using immunohistochemistry, quantitative polymerase chain reaction and fluorogenic peptide substrate in lesional and nonlesional psoriasis skin. We additionally measured the plasmatic proteasome (p‐proteasome) levels using enzyme‐linked immunosorbent assay. Results We reveal an increased expression of proteasome and immunoproteasome subunits but stable mRNA levels in lesional psoriasis skin as compared with nonlesional psoriasis skin (n =19), suggesting that proteasome and immunoproteasome expression is regulated post‐transcriptionally. This proteasome overexpression was associated with a significant increase of the proteasomal chymotrypsin‐like activity that was threefold higher in lesional skin than in nonlesional skin (n =3). p‐Proteasome levels were enhanced in patients with psoriasis (mean ± SEM 3960 ± 299 ng mL−1, range 1484–8987) when compared with controls (2535 ± 187 ng mL−1, range 654–6446, P <0·001) and were significantly higher in psoriatic arthritis (4937 ± 572 ng mL−1, range 2600–8987). In addition, they were correlated to the body surface area involved and appeared thus as a new biomarker of psoriasis severity. Conclusions Altogether these results strongly suggest the involvement of the proteasome system in the pathogenesis of psoriasis and support the relevance of proteasome inhibitors in local or systemic treatment of psoriasis." @default.
• W1570364834 created "2016-06-24" @default.
• W1570364834 creator A5002804917 @default.
• W1570364834 creator A5010254222 @default.
• W1570364834 creator A5020037049 @default.
• W1570364834 creator A5027578756 @default.
• W1570364834 creator A5039897403 @default.
• W1570364834 creator A5043573055 @default.
• W1570364834 creator A5052978566 @default.
• W1570364834 creator A5074277221 @default.
• W1570364834 creator A5076087104 @default.
• W1570364834 creator A5085661159 @default.
• W1570364834 date "2011-07-11" @default.
• W1570364834 modified "2023-10-18" @default.
• W1570364834 title "Proteolytic activity and expression of the 20S proteasome are increased in psoriasis lesional skin" @default.
• W1570364834 cites W1522511455 @default.
• W1570364834 cites W1984372690 @default.
• W1570364834 cites W1987011447 @default.
• W1570364834 cites W1993705148 @default.
• W1570364834 cites W1995177178 @default.
• W1570364834 cites W2000801381 @default.
• W1570364834 cites W2004783639 @default.
• W1570364834 cites W2010039708 @default.
• W1570364834 cites W2020358318 @default.
• W1570364834 cites W2025108269 @default.
• W1570364834 cites W2029199693 @default.
• W1570364834 cites W2034681915 @default.
• W1570364834 cites W2037196541 @default.
• W1570364834 cites W2038118774 @default.
• W1570364834 cites W2038309633 @default.
• W1570364834 cites W2045051162 @default.
• W1570364834 cites W2057391169 @default.
• W1570364834 cites W2059694525 @default.
• W1570364834 cites W2061215798 @default.
• W1570364834 cites W2064976423 @default.
• W1570364834 cites W2070434454 @default.
• W1570364834 cites W2078114300 @default.
• W1570364834 cites W2079123938 @default.
• W1570364834 cites W2083091516 @default.
• W1570364834 cites W2083104350 @default.
• W1570364834 cites W2107727832 @default.
• W1570364834 cites W2112190271 @default.
• W1570364834 cites W2126690433 @default.
• W1570364834 cites W2127758731 @default.
• W1570364834 cites W2165374926 @default.
• W1570364834 cites W2167779091 @default.
• W1570364834 cites W2178503716 @default.
• W1570364834 cites W4250618101 @default.
• W1570364834 doi "https://doi.org/10.1111/j.1365-2133.2011.10447.x" @default.
• W1570364834 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21740404" @default.
• W1570364834 hasPublicationYear "2011" @default.
• W1570364834 type Work @default.
• W1570364834 sameAs 1570364834 @default.
• W1570364834 citedByCount "15" @default.
• W1570364834 countsByYear W15703648342014 @default.
• W1570364834 countsByYear W15703648342015 @default.
• W1570364834 countsByYear W15703648342016 @default.
• W1570364834 countsByYear W15703648342017 @default.
• W1570364834 countsByYear W15703648342018 @default.
• W1570364834 countsByYear W15703648342019 @default.
• W1570364834 countsByYear W15703648342020 @default.
• W1570364834 countsByYear W15703648342021 @default.
• W1570364834 countsByYear W15703648342022 @default.
• W1570364834 countsByYear W15703648342023 @default.
• W1570364834 crossrefType "journal-article" @default.
• W1570364834 hasAuthorship W1570364834A5002804917 @default.
• W1570364834 hasAuthorship W1570364834A5010254222 @default.
• W1570364834 hasAuthorship W1570364834A5020037049 @default.
• W1570364834 hasAuthorship W1570364834A5027578756 @default.
• W1570364834 hasAuthorship W1570364834A5039897403 @default.
• W1570364834 hasAuthorship W1570364834A5043573055 @default.
• W1570364834 hasAuthorship W1570364834A5052978566 @default.
• W1570364834 hasAuthorship W1570364834A5074277221 @default.
• W1570364834 hasAuthorship W1570364834A5076087104 @default.
• W1570364834 hasAuthorship W1570364834A5085661159 @default.
• W1570364834 hasConcept C126322002 @default.
• W1570364834 hasConcept C203014093 @default.
• W1570364834 hasConcept C204232928 @default.
• W1570364834 hasConcept C27740335 @default.
• W1570364834 hasConcept C2780564577 @default.
• W1570364834 hasConcept C2780942790 @default.
• W1570364834 hasConcept C55493867 @default.
• W1570364834 hasConcept C71924100 @default.
• W1570364834 hasConcept C86803240 @default.
• W1570364834 hasConceptScore W1570364834C126322002 @default.
• W1570364834 hasConceptScore W1570364834C203014093 @default.
• W1570364834 hasConceptScore W1570364834C204232928 @default.
• W1570364834 hasConceptScore W1570364834C27740335 @default.
• W1570364834 hasConceptScore W1570364834C2780564577 @default.
• W1570364834 hasConceptScore W1570364834C2780942790 @default.
• W1570364834 hasConceptScore W1570364834C55493867 @default.
• W1570364834 hasConceptScore W1570364834C71924100 @default.
• W1570364834 hasConceptScore W1570364834C86803240 @default.
• W1570364834 hasIssue "2" @default.
• W1570364834 hasLocation W15703648341 @default.
• W1570364834 hasLocation W15703648342 @default.
• W1570364834 hasOpenAccess W1570364834 @default.
• W1570364834 hasPrimaryLocation W15703648341 @default.

• next